Search Results - Neeta Pandit‐Taskar

Refine Results
  1. 1
    Norepinephrine Transporter as a Target for Imaging and Therapy

    Norepinephrine Transporter as a Target for Imaging and Therapy by Neeta Pandit‐Taskar, Shakeel Modak

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Novel Tracers and Their Development for the Imaging of Metastatic Prostate Cancer

    Novel Tracers and Their Development for the Imaging of Metastatic Prostate Cancer by Andrea B. Apolo, Neeta Pandit‐Taskar, Michael J. Morris

    Published 2008
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Bone-Seeking Radiopharmaceuticals for Treatment of Osseous Metastases, Part 1: α Therapy with <sup>223</sup>Ra-Dichloride

    Bone-Seeking Radiopharmaceuticals for Treatment of Osseous Metastases, Part 1: α Therapy with <sup>223</sup>Ra-Dichloride by Neeta Pandit‐Taskar, Steven M. Larson, Jorge A. Carrasquillo

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates

    Radiation dosimetry of 18F-FDG PET/CT: incorporating exam-specific parameters in dose estimates by Brian Quinn, Z. L. Dauer, Neeta Pandit‐Taskar, Heiko Schöder, Lawrence T. Dauer

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Molecular Imaging of Biomarkers in Breast Cancer

    Molecular Imaging of Biomarkers in Breast Cancer by Gary A. Ulaner, Christopher C. Riedl, Maura N. Dickler, Komal Jhaveri, Neeta Pandit‐Taskar, Wolfgang Weber

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Patient-specific organ and effective dose estimates in pediatric oncology computed tomography

    Patient-specific organ and effective dose estimates in pediatric oncology computed tomography by Yiming Gao, Brian Quinn, Neeta Pandit‐Taskar, Gerald Behr, Usman Mahmood, D Long, Xiaobin Xu, Jean St. Germain, Lawrence T. Dauer

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Key role for myeloid cells: Phase II results of anti‐G<sub>D2</sub> antibody 3F8 plus granulocyte‐macrophage colony‐stimulating factor for chemoresistant osteomedullary neuroblastoma

    Key role for myeloid cells: Phase II results of anti‐G<sub>D2</sub> antibody 3F8 plus granulocyte‐macrophage colony‐stimulating factor for chemoresistant osteomedullary neuroblasto... by Nai‐Kong V. Cheung, Irene Y. Cheung, Kim Kramer, Shakeel Modak, Deborah Kuk, Neeta Pandit‐Taskar, Elizabeth Chamberlain, Irina Ostrovnaya, Brian H. Kushner

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Recurrent Ovarian Cancer: Use of Contrast-enhanced CT and PET/CT to Accurately Localize Tumor Recurrence and to Predict Patients’ Survival

    Recurrent Ovarian Cancer: Use of Contrast-enhanced CT and PET/CT to Accurately Localize Tumor Recurrence and to Predict Patients’ Survival by Evis Sala, Masako Kataoka, Neeta Pandit‐Taskar, Nicole Ishill, Svetlana Mironov, Chaya S. Moskowitz, Oleg Mironov, Michelle A. Collins, S. Dennis, Steven M. Larson, Hedvig Hricak

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Feasibility and Predictability of Perioperative PET and Estrogen Receptor Ligand in Patients with Invasive Breast Cancer

    Feasibility and Predictability of Perioperative PET and Estrogen Receptor Ligand in Patients with Invasive Breast Cancer by Mary L. Gemignani, Sujata Patil, Venkatraman Seshan, Michelle Sampson, John L. Humm, Jason S. Lewis, Edi Brogi, Steven M. Larson, Monica Morrow, Neeta Pandit‐Taskar

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Biodistribution and radiation dose estimates for 68Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors

    Biodistribution and radiation dose estimates for 68Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors by Simone Krebs, Neeta Pandit‐Taskar, Diane Reidy‐Lagunes, Bradley J. Beattie, Serge K. Lyashchenko, Jason S. Lewis, Lisa Bodei, Wolfgang Weber, Joseph A. O’Donoghue

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Sentinel lymph node biopsy in the management of early-stage cervical carcinoma

    Sentinel lymph node biopsy in the management of early-stage cervical carcinoma by John P. Diaz, Mary L. Gemignani, Neeta Pandit‐Taskar, Kay J. Park, Melissa P. Murray, S. Dennis, Yukio Sonoda, Richard R. Barakat, Nadeem R. Abu‐Rustum

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    A comparison of pediatric and adult CT organ dose estimation methods

    A comparison of pediatric and adult CT organ dose estimation methods by Yiming Gao, Brian Quinn, Usman Mahmood, D Long, Yusuf E. Erdi, Jean St. Germain, Neeta Pandit‐Taskar, X. George Xu, Wesley E. Bolch, Lawrence T. Dauer

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Impact of pre-operative positron emission tomography in gallbladder cancer

    Impact of pre-operative positron emission tomography in gallbladder cancer by Universe Leung, Neeta Pandit‐Taskar, Carlos U. Corvera, Michael I. D’Angelica, Peter J. Allen, T. Peter Kingham, Ronald P. DeMatteo, William R. Jarnagin, Yuman Fong

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Antibody Mass Escalation Study in Patients with Castration-Resistant Prostate Cancer Using <sup>111</sup>In-J591: Lesion Detectability and Dosimetric Projections for <sup>90</sup>Y Radioimmunotherapy

    Antibody Mass Escalation Study in Patients with Castration-Resistant Prostate Cancer Using <sup>111</sup>In-J591: Lesion Detectability and Dosimetric Projections for <sup>90</sup>Y... by Neeta Pandit‐Taskar, Joseph A. O’Donoghue, Michael J. Morris, Eze A. Wills, Lawrence H. Schwartz, Mithat Gönen, Howard I. Scher, Steven M. Larson, Chaitanya Divgi

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Sentinel lymph node mapping for grade 1 endometrial cancer: Is it the answer to the surgical staging dilemma?

    Sentinel lymph node mapping for grade 1 endometrial cancer: Is it the answer to the surgical staging dilemma? by Nadeem R. Abu‐Rustum, Fady Khoury‐Collado, Neeta Pandit‐Taskar, Robert A. Soslow, Fanny Dao, Yukio Sonoda, Douglas A. Levine, Carol L. Brown, S. Dennis, Richard R. Barakat, Mary L. Gemignani

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist 177Lu-Satoreotide Tetraxetan

    Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist 177Lu-Satoreotide Tetraxetan by Diane Reidy‐Lagunes, Neeta Pandit‐Taskar, Joseph A. O’Donoghue, Simone Krebs, Kevin D. Staton, Serge K. Lyashchenko, Jason S. Lewis, Nitya Raj, Mithat Gönen, Christian Lohrmann, Lisa Bodei, Wolfgang Weber

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Phase I Trial of Selective Internal Radiation Therapy for Chemorefractory Colorectal Cancer Liver Metastases Progressing After Hepatic Arterial Pump and Systemic Chemotherapy

    Phase I Trial of Selective Internal Radiation Therapy for Chemorefractory Colorectal Cancer Liver Metastases Progressing After Hepatic Arterial Pump and Systemic Chemotherapy by Constantinos T. Sofocleous, Alessandra R. Garcia, Neeta Pandit‐Taskar, Richard Kinh Gian, Lynn A. Brody, Elena N. Petre, Marinela Capanu, Anne P. Longing, Joanne F. Chou, Jorge A. Carrasquillo, Nancy E. Kemeny

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Sequential Cytarabine and α-Particle Immunotherapy with Bismuth-213–Lintuzumab (HuM195) for Acute Myeloid Leukemia

    Sequential Cytarabine and α-Particle Immunotherapy with Bismuth-213–Lintuzumab (HuM195) for Acute Myeloid Leukemia by Todd Rosenblat, Michael R. McDevitt, Deborah Mulford, Neeta Pandit‐Taskar, Chaitanya Divgi, Katherine S. Panageas, Mark Heaney, Suzanne Chanel, Alfred Morgenstern, George Sgouros, Steven M. Larson, David A. Scheinberg, Joseph G. Jurcic

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumors

    Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumors by Neeta Pandit‐Taskar, Joseph A. O’Donoghue, Chaitanya Divgi, Eze A. Wills, Lawrence H. Schwartz, Mithat Gönen, Peter Smith‐Jones, Neil H. Bander, Howard I. Scher, Steven M. Larson, Michael J. Morris

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer

    Retooling a Blood-Based Biomarker: Phase I Assessment of the High-Affinity CA19-9 Antibody HuMab-5B1 for Immuno-PET Imaging of Pancreatic Cancer by Christian Lohrmann, Eileen M. O’Reilly, Joseph A. O’Donoghue, Neeta Pandit‐Taskar, Jorge A. Carrasquillo, Serge K. Lyashchenko, Shutian Ruan, Rebecca Teng, Wolfgang Scholz, Paul W. Maffuid, Jason S. Lewis, Wolfgang Weber

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: